PROGRESS IN MANAGEMENT OF LOCALLY ADVANCED RECTAL CANCER

Read full text Summarise with VIRAT
Authors: Dragoş Voicu, Adrian Drăgan
Cited by: 0
References: 13

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

The incidence of rectal cancer, particularly among younger adults, has risen substantially over recent decades [1], prompting renewed focus on optimizing diagnostic and therapeutic strategies. Management has evolved from surgery alone to a multimodal approach integrating chemoradiation, total mesorectal excision (TME), and systemic chemotherapy. Landmark clinical trials have shaped current standards, demonstrating improvements in local control and disease-free survival. More recently, total neoadjuvant therapy (TNT) has redefined treatment sequencing by delivering all systemic therapy before surgery, enhancing tumor response and reducing distant metastases [8,9]. Additionally, organ-preserving approaches, including non-operative management for patients achieving a complete clinical response, are increasingly being explored [14,15]. This review summarizes the historical development of rectal cancer management, highlights pivotal clinical trials, and discusses emerging strategies that may further individualize therapy.

Fields of Study & Subjects

Colorectal Cancer Surgical Treatments Colorectal and Anal Carcinomas Prostate Cancer Diagnosis and Treatment

Publication details

Journal / source
The Scientific Heritage
Publication date
31 March 2026
Language
EN